An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections NOVIR
Updated on September 1, 2021 — Creative Commons Attribution 4.0
Mas Pharmaceuticals
Mas Pharmaceuticals is a Bioceutical R&D Performing Biotechnology Company located in Istanbul , Turkey. Mas Pharmaceuticals holds the ownership of 128 Pharmaceutical and Bioceutical Patents' Exclusive License Rights which are invented by Mr. Erdal Can ALKOCLAR and Mr. Metehan YESIL. Mas…
1 datasets
Informations
- License
- Creative Commons Attribution 4.0
- ID
- 5e9f437dd2bfb22b625b457e
Temporality
- Frequency
- Quarterly
- Creation date
- April 21, 2020
- Latest resource update
- April 21, 2020
Embed
Permalink
Description
An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA Gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms Simultaneously.
Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL
Files 3
Community resources 0
You have built a more comprehensive database than those presented here? This is the time to share it!
Reuses 0
Explore the reuses of this dataset.
Did you use this data ? Reference your work and increase your visibility.
Discussion between the organization and the community about this dataset.